This week, Beyond Biotech examined how Europe's biotech ecosystem is evolving through new venture models, focusing on Argobio's approach to identifying and scaling the continent's most promising companies. The episode explores the structural challenges European founders face compared to their US counterparts, and how targeted venture strategies might help bridge that gap. It's a timely look at whether Europe can develop homegrown biotech champions or remains dependent on external capital and talent.
Episodes This Week
Get a free sample digest — no signup needed
Real AI summaries from top beyond biotech podcasts, straight to your inbox.
or
No spam, unsubscribe anytime. We'll send one sample digest, then you decide.